Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neuro-MoD: Neuroplasticity With Motor Development

NCT: NCT07738432 · NOT_YET_RECRUITING

NCT IDNCT07738432
StatusNOT_YET_RECRUITING
Start Date2026-08
Completion2027-06
SponsorUniversity of Wisconsin, Madison (OTHER)
First posted
Last updated

Brief Summary

This study is for infants and toddlers between 8 and 24 months old who use one arm and/or hand differently following a perinatal brain injury. This is a time when investigators think they can best help improve how the brain controls movement. Investigators are testing whether the combination of transcutaneous auricular vagus nerve stimulation (taVNS) with 40 hours of constraint-induced movement therapy (CIMT) can help infants move their weaker arm and hand better and make the brain pathways for movement stronger.

Frequently Asked Questions

What is Neuro-MoD: Neuroplasticity With Motor Development?

Neuro-MoD: Neuroplasticity With Motor Development is a clinical trial registered under NCT07738432. Current status: NOT_YET_RECRUITING.

What is the status of NCT07738432?

The current status of NCT07738432 (Neuro-MoD: Neuroplasticity With Motor Development) is: NOT_YET_RECRUITING.

When did Neuro-MoD: Neuroplasticity With Motor Development start?

Neuro-MoD: Neuroplasticity With Motor Development started on 2026-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.